The BSG Oesophageal Section Education Symposium will appeal to a wide audience, including the nurses section and members of AGIP.
Attendees will hear talks on Barrett's management, endoscopy quality, achalasia diagnosis and endoscopic and surgical management. There will also be an update on the Aspect trial’s results and their implications. Findings from this trial were published in the August 2018 edition of The Lancet.
This symposium has been approved by the Federation of The Royal Colleges of Physicians of the United Kingdom for 5 CPD credits.
Book now to secure your space!
The meeting will be held at the Royal College of Physicians London.
The infomation below has been taken from the RCP website.
Planning your visit
Visitors who require extra assistance or specialist facilities can either speak to a member of staff when they arrive or book in advance.
The RCP offers free parking for disabled visitors. Spaces are limited so please contact us at least 24 hours in advance so that we can make the necessary arrangements to ensure a parking bay is available.
Guide and hearing dogs
We welcome guide dogs and hearing dogs in the gallery. A drinking bowl is available at the cloakroom – just ask a member of staff.
Main building accessibility
A lift platform is situated along the black rails to the left of the building's main entrance*. There is also an inward opening automatic door at the front of the building, giving access to the main reception area and Wolfson Theatre.
*Please note that the lift platform is currently undergoing maintenance, and is out of service. Please contact us by phone +44 (0)20 3075 1363 or email email@example.com if you have concerns or want to discuss your visit.
10:00 - 10:30 Endoscopy Jason Dunn
10:30 - 11:00 Nurse Endoscopist and Barrett’s Clinical Nurse Specialist Role Jo Harvey
11:00 - 11:30 Endoscopic Mucosal Resection Rehan Haidry
11:30 - 12:00 Mucosal Ablation David Graham
12:20 - 12:40 Aspect Trial Results Janusz Jankowski
12:40 - 13:00 Aspect Trial - Impact of Results on Future Management of Barrett’s Oesophagus John de Caestecker
14:15 - 14:45 Diagnosis Nigel Trudgill
14:45 - 15:15 Overview of Therapy Rami Sweis
The biennial BSG oesophageal section symposium on 19th November focused on the state of the art in the management of Barrett’s oesophagus and achalasia.
- In Barrett’s oesophagus, the importance of high quality surveillance on dedicated endoscopy lists, undertaken by appropriately trained endoscopists with sufficient time for the procedures was emphasised, to enable subsequent endotherapy when needed. Following endoscopy, the contribution of holistic specialist nursing care in helping patients manage the anxieties of their pre-malignant condition and its therapy was shown.
- The AspECT study results have clearly shown the value of high dose twice daily proton pump inhibitors in patients with Barrett’s oesophagus in preventing all cause mortality and the development of cancer or high grade dysplasia but also that there is no role for aspirin in Barrett’s oesophagus.
- High resolution manometry is crucial to diagnose and prognosticate in achalasia. Pneumatic dilatation and Heller’s myotomy have established roles in therapy with sustained long term benefits and established risks. Per-oral endoscopic myotomy (POEM) is a potentially attractive alternative therapy but there are still no controlled data against pneumatic dilatation or myotomy and this is required before POEM can be recommended outside of a clinical trial.